home contact company.overview news sitemap print

Screening & Optimization
Structure-based Drug Design
Stem Cell-based Approaches
Cardiac Safety

High content imaging (endpoint / live cell)
Assay development for compound screening / target validation
Phenotypic screening
Chromobody® cell lines on demand

DigiWest High Content Profiling
RPPA-based Pathway Mapping
Ultrasensitive Protein Profiling
Custom Multiplex Immunoassays

Gene cloning and expression services
Lentiviral transduction technologies
Full range of cellular assays

GMP Analysis
Method Development and Validation
Consulting for GMP or GLP Issues


NMI TT is a subsidiary of NMI